spacer
home > pmps > autumn 2018 > bracing for brexit
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Bracing for Brexit

PMPS:Can you summarise why Brexit will impact pharmacovigilance (PV)?

Dr Jackie Roberts: The decision and process of leaving the EU after the referendum vote had, and continues to have, a significant knock-on effect for UK-based businesses, particularly pharmaceutical manufacturers.

The industry relies on being able to manufacture, supply, and distribute across Europe, enabling products to reach patients quickly and safely with relative ease.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Jackie Roberts is the Executive Director responsible for regulatory, pharmacovigilance, medical, and healthcare compliance at Accord Healthcare. She is also the Qualified Person for pharmacovigilance at the company. She has a PhD in clinical pharmacology from Imperial College in London, UK, and an MBA with distinction from Warwick Business School, UK. Jackie’s experience spans the industry, contract research organisations, and the UK regulatory authority.
spacer
Dr Jackie Roberts
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ACG to Showcase its Range of Capsules and Engineering Solutions at Supply Side West, Las Vegas

ACG, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical and the nutraceutical industries, will be exhibiting its wide range of Engineering and Capsules solutions at this year’s Supply Side West, Las Vegas. At ACG’s booth, the visitors will be able to see the synergies created with coupling ACG’s Capsules and Engineering products, thereby leveraging the many benefits of integrated manufacturing.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

SMi Presents the 13th Annual Conference: Parallel Trade 2019

5-6 February 2019, Holiday Inn Kensington Forum, London

SMi presents its 13th annual Parallel Trade conference, taking place in London on the 5th-6th of February 2019. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement